全球糞便鈣衛蛋白檢測市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計糞便鈣衛蛋白檢測市場將從 2025 年的 51.4 億美元成長到 2034 年的 141.2 億美元，2026 年至 2034 年的複合年成長率為 11.89%。

隨著醫療機構日益重視胃腸道疾病的早期檢測和監測，糞便鈣衛蛋白（CHL）檢測市場正蓬勃發展。鈣衛蛋白是一種腸道發炎生物標記物，擴大用於診斷發炎性腸道疾病（IBD）、克隆氏症、潰瘍性大腸炎和其他疾病。隨著全球慢性胃腸道疾病負擔的加重，對可靠、非侵入性檢測方法的需求預計將加速成長。

技術進步正在提高診斷的準確性和效率。就地檢驗盒能夠快速提供檢測結果，有助於提高患者的治療依從性，並為制定合適的治療方案提供支援。自動化免疫檢測和酵素連結免疫吸附試驗（ELISA）平台簡化了檢查室操作，而數位資料管理則實現了檢測結果與電子健康記錄的整合。這些進步正在改善全球醫療保健系統的臨床療效和營運效率。

未來市場擴張將受個人化醫療和預防醫學的影響。隨著臨床醫生擴大採用基於生物標記的疾病管理方法，糞便鈣衛蛋白檢測將在減少大腸鏡檢查等侵入性操作方面發揮關鍵作用。新興經濟體預計將迎來顯著成長，這得益於公眾意識的提高和醫療基礎設施的不斷改善。創新和可近性的提升推動了此檢測方法的應用，使其成為全球診斷領域的重要組成部分。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球糞便鈣衛蛋白檢測市場：依檢測方法分類

• 市場分析、洞察與預測
• 酵素免疫分析法
• 酵素螢光免疫分析
• 定量層析法

第5章：全球糞便鈣衛蛋白檢測市場：依應用分類

• 市場分析、洞察與預測
• 發炎性腸道疾病
• 結腸癌
• 其他

第6章：全球糞便鈣衛蛋白檢測市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院和診所
• 診斷檢查室
• 學術研究機構

第7章 全球糞便鈣衛蛋白檢測市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Epitope Diagnostics Inc
  • Hycult Biotech
  • Actim, Eagle BiosciencesInc
  • Operon
  • Svar Life Science
  • BA1/4Hlmann
  • DRG International Inc
  • ALPCO
  • Diazyme Laboratories

The Faecal Calprotectin Testing Market size is expected to reach USD 14.12 Billion in 2034 from USD 5.14 Billion (2025) growing at a CAGR of 11.89% during 2026-2034.

The faecal calprotectin testing market is gaining momentum as healthcare providers emphasize early detection and monitoring of gastrointestinal diseases. Calprotectin, a biomarker of intestinal inflammation, is increasingly used in diagnosing conditions such as inflammatory bowel disease (IBD), Crohn's disease, and ulcerative colitis. With the global burden of chronic digestive disorders on the rise, demand for reliable, non-invasive testing methods is expected to accelerate.

Technological progress is enhancing diagnostic accuracy and efficiency. Point-of-care testing kits are enabling rapid results, improving patient compliance, and supporting timely treatment decisions. Automated immunoassays and ELISA platforms are streamlining laboratory workflows, while digital data management is integrating test results with electronic health records. These advancements are improving both clinical outcomes and operational efficiency for healthcare systems worldwide.

Future market expansion will be shaped by personalized medicine and preventive healthcare. As clinicians increasingly adopt biomarker-based approaches for disease management, faecal calprotectin testing will play a crucial role in reducing invasive procedures such as colonoscopy. Emerging economies are expected to witness significant growth, supported by rising awareness and expanding healthcare infrastructure. With innovation and accessibility driving adoption, this testing market is positioned as a vital component of the global diagnostic landscape.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Assay

• Enzyme-linked Immunosorbent Assay
• Enzyme Fluroimmunoassay
• Quantitative Immunochromatography

By Application

• Inflammatory Bowel Disease
• Colorectal Cancer
• Others

By End-use

• Hospitals And Clinics
• Diagnostic Laboratories
• Academic And Research Institutes

COMPANIES PROFILED

• Epitope Diagnostics Inc, Hycult Biotech, Actim, Eagle Biosciences, Inc, Operon, Svar Life Science, Bhlmann, DRG International Inc, ALPCO, Diazyme Laboratories
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL FAECAL CALPROTECTIN TESTING MARKET: BY ASSAY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Assay
• 4.2. Enzyme-linked Immunosorbent Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Enzyme Fluroimmunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Quantitative Immunochromatography Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL FAECAL CALPROTECTIN TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Inflammatory Bowel Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Colorectal Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL FAECAL CALPROTECTIN TESTING MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Academic And Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL FAECAL CALPROTECTIN TESTING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Assay
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Assay
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Assay
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Assay
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Assay
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL FAECAL CALPROTECTIN TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Epitope Diagnostics Inc
  • 9.2.2 Hycult Biotech
  • 9.2.3 Actim, Eagle BiosciencesInc
  • 9.2.4 Operon
  • 9.2.5 Svar Life Science
  • 9.2.6 BA1/4Hlmann
  • 9.2.7 DRG International Inc
  • 9.2.8 ALPCO
  • 9.2.9 Diazyme Laboratories